Indications
Treatment of symptomatic chronic heart failure
Composition
- Active substance
- vericiguat
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Verquvo
- Active substance
- vericiguat
- ATC code
- C01
- Therapeutic area
- Heart Failure
- Marketing authorisation holder
- Bayer AG
- Status
- Authorised
- EU authorisation
- 16 Jul 2021
- EMA product number
- EMEA/H/C/005319